CEO SUMMARY: Over-utilization is likely to be a prime concern when federal healthcare enforcers eventually investigate in-house anatomic pathology laboratories owned by specialist physicians. Some in-house pathology lab condo promoters are basing financial performance on 100% utilization of 12-core prostate biopsies. That significantly exceeds current clinical practices, as the numbers below demonstrate. OVER-UTILIZATION WILL BE […]
AP Test Over-Utilization Will Be One Achilles’ Heel
12-core prostate biopsies may quickly attract attention of federal investigators
- By Robert Michel
- > From the Volume XI No. 11 - August 9, 2004 Issue
- Tags: anatomic pathologist, Anatomic pathology, anatomic pathology lab, anatomic pathology laboratory, biopsies, biopsy, compliance requirements, cpt, cpt code, dark report, healthcare fraud, impac, lab compliance, lab industry, laboratories, Medicare, pathologists, Pathology group, pathology lab, pathology laboratories, pathology laboratory, pathology service, pathology service associates, private payer, prostate biopsy, the dark report
